Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 286 AL 300

Management of Alzheimer's disease and related neurotoxic pathologies: Role of thiamine, pyridoxine and cobalamin

Ekundayo BE, Adewale OB, Obafemi BA, Afolabi OB, Obafemi TO.

Eur J Pharmacol. 2024 Nov 5;982:176958. doi: 10.1016/j.ejphar.2024.176958. Epub 2024 Aug 30.

Irisin in ischemic stroke, Alzheimer's disease and depression: a Narrative Review

Zhang QX, Zhang LJ, Zhao N, Yang L.

Brain Res. 2024 Dec 15;1845:149192. doi: 10.1016/j.brainres.2024.149192. Epub 2024 Aug 28.

Glymphotherapeutics for Alzheimer's disease: Time to move the needle

MohanaSundaram A, Mofatteh M, Ashraf GM, Praticò D.

Ageing Res Rev. 2024 Nov;101:102478. doi: 10.1016/j.arr.2024.102478. Epub 2024 Aug 31.

Emerging Roles of Adaptive Immune Response in Alzheimer's Disease

Li C, Zhao Q, Feng L, Li M.

Aging Dis. 2024 Aug 12;16(4):2315-2342. doi: 10.14336/AD.2024.0564.

Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer's Disease: Recent Advances and Therapeutic Implications

Rahman MA, Rahman MDH, Rhim H, Kim B.

Curr Neuropharmacol. 2024;22(12):1942-1959. doi: 10.2174/1570159X22666240426091311.

AMPA receptors in Alzheimer disease: Pathological changes and potential therapeutic targets

Ning L, Shen R, Xie B, Jiang Y, Geng X, Dong W.

J Neuropathol Exp Neurol. 2024 Nov 1;83(11):895-906. doi: 10.1093/jnen/nlae093.

Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease

Zhao X, Hu Q, Wang X, Li C, Chen X, Zhao D, Qiu Y, Xu H, Wang J, Ren L, Zhang N, Li S, Gong P, Hou Y.

Eur J Med Chem. 2024 Dec 5;279:116810. doi: 10.1016/j.ejmech.2024.116810. Epub 2024 Sep 4.

Role of the X Chromosome in Alzheimer Disease Genetics

Belloy ME, Le Guen Y, Stewart I, Williams K, Herz J, Sherva R, Zhang R, Merritt V, Panizzon MS, Hauger RL, Gaziano JM, Logue M, Napolioni V, Greicius MD.

JAMA Neurol. 2024 Oct 1;81(10):1032-1042. doi: 10.1001/jamaneurol.2024.2843.

[Anti-amyloid Antibody Drugs as Disease-Modifying Therapies for Alzheimer's Disease]

Sato K, Iwatsubo T.

Brain Nerve. 2024 Sep;76(9):991-995. doi: 10.11477/mf.1416202723.

[Novel Therapeutic Strategies for Alzheimer's Disease]

Tomita T.

Brain Nerve. 2024 Sep;76(9):1053-1058. doi: 10.11477/mf.1416202732.

Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis

Reddy AP, Rawat P, Rohr N, Alvir R, Bisht J, Bushra MA, Luong J, Reddy AP.

Aging Dis. 2024 Mar 28;16(2):841-858. doi: 10.14336/AD.2024.0328.

Alzheimer's Disease Has Its Origins in Early Life via a Perturbed Microbiome

Ginsberg SD, Blaser MJ.

J Infect Dis. 2024 Sep 10;230(Supplement_2):S141-S149. doi: 10.1093/infdis/jiae200.

Amyloid-β-targeting immunotherapies for Alzheimer's disease

Jin Y, Du Q, Song M, Kang R, Zhou J, Zhang H, Ding Y.

J Control Release. 2024 Nov;375:346-365. doi: 10.1016/j.jconrel.2024.09.012. Epub 2024 Sep 18.

Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease

Serradas ML, Ding Y, Martorell PV, Kulińska I, Castro-Gomez S.

Cells. 2024 Aug 26;13(17):1426. doi: 10.3390/cells13171426.

Alzheimer's Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions

Dey A, Ghosh S, Rajendran RL, Bhuniya T, Das P, Bhattacharjee B, Das S, Mahajan AA, Samant A, Krishnan A, Ahn BC, Gangadaran P.

Int J Mol Sci. 2024 Sep 7;25(17):9690. doi: 10.3390/ijms25179690.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias